Thymogen: what the limited human immune research shows

## What is it? Thymogen is a synthetic glutamyl-tryptophan dipeptide investigated as an immunomodulator. It is different from thymosin alpha-1 and thymalin, despite similar names and marketing. [1]

## What do studies show? A 2011 double-blind, randomized, placebo-controlled study in older patients preparing for surgery for abdominal or retroperitoneal solid tumors reported changes in cellular-immunity measures and fewer postoperative complications with an intranasal Thymogen preparation. The abstract does not provide enough detail to judge all methods and adverse events. A specialized perioperative finding does not show that routine use prevents infection or improves immunity in otherwise healthy adults, nor that a supplier vial is equivalent to that intranasal preparation. [1]

## Safety Immune interventions may matter particularly for people with cancer, autoimmune disease, immunosuppressive treatment, or transplant history. Product identity, formulation, and long-term safety of a catalog vial are not established by this one trial. [1]

## How much? The cited study used an intranasal preparation for seven days before surgery in a supervised clinical setting. Its regimen is not a self-injection protocol or a general wellness dose. No safe and effective adult wellness schedule, or reliably attributable anecdotal dose for this exact vial, was established. [1]